This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CPHI Online is the largest global marketplace in the pharma ingredients industry

  • Products
    0
  • Companies
    0
  • Articles
    0
  • Events
    0
  • Webinars
    0
News
31 Aug 2020

Pep2Dia, an innovative ingredient designed for healthy blood sugar levels

Pep2Dia for healhy blood sugar level

Pep2Dia® is a patented milk protein hydrolysate with an active dipeptide AP, specifically designed for blood sugar levels. AP peptide acts as an inhibitor of the alpha glucosidase. This digestive enzyme hydrolyses polysaccharides into glucose and allows absorption. Its inhibition lowers blood sugar levels.

Today more than 350 million people live with high blood sugar glucose (1). In 5 to 10 years, if nothing is done, the people with prediabetes, who have a higher-than-normal glycaemia in the morning fasting, will become diabetic. Everywhere, diabetes is on the rise and affects 8.5% of the adult population (2).

Pep2Dia® is the result of extensive research and collaboration between Ingredia’s scientists and LIENSs-CNRS La Rochelle University in France. 
Pep2Dia® has proven efficacy on glycaemia after meals.
Pre-clinical and clinical studies support Pep2Dia®’s action to reduce postprandial glycaemia with a significative effect versus the placebo.

Mentioned Companies
INGREDIA
View company profile

Related News